Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Business
Mark Sweney

Staffordshire-based Instem bought by private equity group for £203m

Instem provides IT services used in drug development for the global life sciences market.
Instem provides IT services used in drug development for the global life sciences market. Photograph: David Davies/PA

London-listed Instem has been taken private in a £200m deal marking the second British life sciences company this week to be snapped up as foreign buyers target the UK for cheap takeover deals.

The Staffordshire-based company, which provides IT services used in drug development for the global life sciences market, has been acquired by French healthcare-focused private equity group Archimed SAS for £203m.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.